Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant.

Journal of neuro-oncology - 1 Sept 2024

Ozono Iori, Onishi Shumpei, Yonezawa Ushio, Taguchi Akira, Khairunnisa Novita Ikbar, Amatya Vishwa Jeet, Yamasaki Fumiyuki, Takeshima Yukio, Horie Nobutaka

Abstract excerpt

PURPOSE: The T2-FLAIR mismatch sign is a highly specific diagnostic imaging biomarker for astrocytoma, IDH-mutant. However, a definitive prognostic imaging biomarker has yet to be identified. This study investigated imaging prognostic markers, specifically analyzing T2-weighted and FLAIR images of this tumor. METHODS: We retrospectively analyzed 31 cases of non-enhancing astrocytoma, IDH-mutant treated at our...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Brain Neoplasms

Share to Follow-Up Studies

Share to Isocitrate Dehydrogenase

Share to Magnetic Resonance Imaging

Share to Prognosis

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 38995493
DOI: 10.1007/s11060-024-04758-4
PMCID: PMC11341624

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Super T2-FLAIR mismatch sign: a prognostic imaging biomarker for non-enhancing astrocytoma, IDH-mutant.PMID 38995493Read ↗

Evaluating the super T2-FLAIR mismatch sign in non-contrast-enhancing oligodendroglioma, IDH-mutant, and 1p/19q codeleted.Semantic proximity Read ↗

T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.Semantic proximity Read ↗

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas.Semantic proximity Read ↗

T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant.Semantic proximity Read ↗

T2-FLAIR Mismatch Positive IDH-mutant Astrocytomas: Can We Identify High-grade Tumors Among them Before Surgery?Semantic proximity Read ↗

"Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.Semantic proximity Read ↗

The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.Semantic proximity Read ↗

Association of partial T2-FLAIR mismatch sign and isocitrate dehydrogenase mutation in WHO grade 4 gliomas: results from the ReSPOND consortium.Semantic proximity Read ↗

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study.Semantic proximity Read ↗

Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas.Semantic proximity Read ↗

Comment on, "T2-FLAIR mismatch sign, an imaging biomarker for CDKN2A-intact in non-enhancing astrocytoma, IDH-mutant".Semantic proximity Read ↗

Clinicopathological and radiological characteristics of false-positive and false-negative results in T2-FLAIR mismatch sign of IDH-mutated gliomas.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.